Insider Transactions
| Date | Name | Title | Type | Shares Traded | Price Range |
|---|---|---|---|---|---|
| Jul 09, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 13,881 | $3.36 |
| Jul 09, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 30, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 8,000 | $3.21 |
| Jun 25, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 24, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 15,773 | $3.21 |
| Jun 23, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 4,167 | $3.35 |
| Jun 23, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Other acquisition or disposition | -- | -- |
| Jun 23, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Other acquisition or disposition | -- | -- |
| Jun 22, 2020 |
Director
|
Director | Open market or private sale of non-derivative or derivative security | 5,000 | $3.25 |
| Jun 22, 2020 |
Chief Medical Officer
|
Chief Medical Officer | Open market or private sale of non-derivative or derivative security | 5,474 | $3.16 |
| Jun 22, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 3,000 | $3.25 |
| Jun 19, 2020 |
Chief Legal Officer
|
Chief Legal Officer | Open market or private sale of non-derivative or derivative security | 3,459 | $3.13 |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 30,000 | -- |
| Jun 18, 2020 |
Director
|
Director | Grant, award or other acquisition pursuant to Rule 16b-3(d) | 60,000 | -- |
* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.